Research Project History

Awardee Organization JOHNS HOPKINS UNIVERSITY
Funding Agency/Organization NIA

Updates

Project Number FY FY Funding Amount Sub-Project Number Project Title PI / Project Leader
5P50AG005146-36 2019 $236907 8808 Core D: Neuropathology Core TRONCOSO, JUAN
5P50AG005146-36 2019 $94753 8809 Core E: Outreach; Recruitment and Education Core ALBERT, MARILYN S
5P50AG005146-36 2019 $196503 8810 Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers BAKKER, ARNOLD
5P50AG005146-36 2019 $206868 8811 A novel AD mouse model for target validation: Abeta accelerates tauopathy-dependent neuronal loss WONG, PHILIP C
5P50AG005146-36 2019 $206867 8812 PICK1 and Abeta induced AMPAR loss in AD HUGANIR, RICHARD L
5P50AG005146-36 2019 $202480 8805 Core A: Administrative Core ALBERT, MARILYN S
5P50AG005146-36 2019 $572607 8806 Core B: Clinical Core LYKETSOS, CONSTANTINE G
5P50AG005146-36 2019 $161744 8807 Core C: Data Management and Statistics Core BANDEEN-ROCHE, KAREN J
5P50AG005146-35 2018 $202756 8805 Core A: Administrative Core Albert, Marilyn
5P50AG005146-35 2018 $573387 8806 Core B: Clinical Core LYKETSOS, CONSTANTINE G
5P50AG005146-35 2018 $161965 8807 Core C: Data Management and Statistics Core BANDEEN-ROCHE, KAREN J
5P50AG005146-35 2018 $237230 8808 Core D: Neuropathology Core TRONCOSO, JUAN
5P50AG005146-35 2018 $94883 8809 Core E: Outreach, Recruitment and Education Core Albert, Marilyn
5P50AG005146-35 2018 $193728 8810 Hippocampal and parietal network changes among subjects in the early phases of AD and relationship with CSF biomarkers BAKKER, ARNOLD
5P50AG005146-35 2018 $207149 8811 A novel AD mouse model for target validation: Abeta accelerates tauopathy-dependent neuronal loss WONG, PHILIP C
5P50AG005146-35 2018 $207147 8812 PICK1 and Abeta induced AMPAR loss in AD HUGANIR, RICHARD L
5P50AG005146-34 2017 $237040 8808 Core D: Neuropathology Core TRONCOSO, JUAN
5P50AG005146-34 2017 $94803 8809 Core E: Outreach, Recruitment and Education Core Albert, Marilyn
5P50AG005146-34 2017 $185131 8810 HIPPOCAMPAL AND PARIETAL NETWORK CHANGES AMONG SUBJECTS IN THE EARLY PHASES OF AD AND RELATIONSHIP WITH CSF BIOMARKERS BAKKER, ARNOLD
3P50AG005146-34S1 2017 $154734 None Johns Hopkins Alzheimers Disease Research Center Albert, Marilyn
5P50AG005146-34 2017 $206978 8812 PICK1 AND ABETA INDUCED AMPAR LOSS IN AD HUGANIR, RICHARD L
5P50AG005146-34 2017 $206979 8811 A NOVEL AD MOUSE MODEL FOR TARGET VALIDATION: ABETA ACCELERATES TAUOPATHY-DEPENDENT NEURONAL LOSS WONG, PHILIP C
5P50AG005146-34 2017 $202593 8805 Core A: Administrative Core Albert, Marilyn
5P50AG005146-34 2017 $572924 8806 Core B: Clinical Core LYKETSOS, CONSTANTINE G
5P50AG005146-34 2017 $161835 8807 Core C: Data Management and Statistics Core BANDEEN-ROCHE, KAREN J
5P50AG005146-33 2016 $221330 8811 A NOVEL AD MOUSE MODEL FOR TARGET VALIDATION: ABETA ACCELERATES TAUOPATHY-DEPENDENT NEURONAL LOSS WONG, PHILIP C
5P50AG005146-33 2016 $202479 8805 CORE A: ADMINISTRATIVE CORE Albert, Marilyn
5P50AG005146-33 2016 $572607 8806 CORE B: CLINICAL CORE LYKETSOS, CONSTANTINE G
5P50AG005146-33 2016 $161744 8807 CORE C: DATA MANAGEMENT AND STATISTICS CORE BANDEEN-ROCHE, KAREN J
5P50AG005146-33 2016 $251369 8808 CORE D: NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-33 2016 $94754 8809 CORE E: OUTREACH, RECRUITMENT AND EDUCATION CORE Albert, Marilyn
5P50AG005146-33 2016 $185572 8810 HIPPOCAMPAL AND PARIETAL NETWORK CHANGES AMONG SUBJECTS IN THE EARLY PHASES OF AD AND RELATIONSHIP WITH CSF BIOMARKERS BAKKER, ARNOLD
5P50AG005146-33 2016 $1896722 None JOHNS HOPKINS ALZHEIMER'S DISEASE RESEARCH CENTER Albert, Marilyn
5P50AG005146-33 2016 $206867 8812 PICK1 AND ABETA INDUCED AMPAR LOSS IN AD HUGANIR, RICHARD L
2P50AG005146-32 2015 $200587 8810 HIPPOCAMPAL AND PARIETAL NETWORK CHANGES AMONG SUBJECTS IN THE EARLY PHASES OF AD AND RELATIONSHIP WITH CSF BIOMARKERS BAKKER, ARNOLD
2P50AG005146-32 2015 $206867 8812 PICK1 AND ABETA INDUCED AMPAR LOSS IN AD HUGANIR, RICHARD L
3P50AG005146-32S1 2015 $200000 None Johns Hopkins Alzheimers Disease Research Center ALBERT, MARILYN S
2P50AG005146-32 2015 $206868 8811 A NOVEL AD MOUSE MODEL FOR TARGET VALIDATION: ABETA ACCELERATES TAUOPATHY-DEPENDENT NEURONAL LOSS WONG, PHILIP C
5P50AG005146-31 2014 $174781 6886 ADMINISTRATIVE CORE Albert, Marilyn
5P50AG005146-31 2014 $555421 6887 CLINICAL CORE Albert, Marilyn
5P50AG005146-31 2014 $156642 6890 DATA MANAGEMENT AND STATISTICS BANDEEN-ROCHE, KAREN J
5P50AG005146-31 2014 $81569 6888 EDUCATION CORE Albert, Marilyn
5P50AG005146-31 2014 $1858673 None JOHNS HOPKINS ALZHEIMER'S DISEASE RESEARCH CENTER Albert, Marilyn
5P50AG005146-31 2014 $222789 6892 MODELING AND ANTI-AMYLOID THERAPY FOR AD: POTENTIAL FOR COGNITIVE RECOVERY SAVONENKO, ALENA
5P50AG005146-31 2014 $216491 6893 NEURONAL ACTIVITY-DEPENDENT SECRETION OF AB AND IMMEDIATE EARLY GENES WORLEY, PAUL F
5P50AG005146-31 2014 $216470 6889 NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-31 2014 $234510 6891 THE ROLES OF AR, TAU AND SYNAPTIC LOSS IN EARLY AD O'BRIEN, RICHARD J
5P50AG005146-30 2013 $153059 6890 DATA MANAGEMENT AND STATISTICS BANDEEN-ROCHE, KAREN J
5P50AG005146-30 2013 $79840 6888 EDUCATION CORE Albert, Marilyn
5P50AG005146-30 2013 $216188 6892 MODELING AND ANTI-AMYLOID THERAPY FOR AD: POTENTIAL FOR COGNITIVE RECOVERY SAVONENKO, ALENA
5P50AG005146-30 2013 $210647 6893 NEURONAL ACTIVITY-DEPENDENT SECRETION OF AB AND IMMEDIATE EARLY GENES WORLEY, PAUL F
5P50AG005146-30 2013 $210684 6889 NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-30 2013 $227498 6891 THE ROLES OF AR, TAU AND SYNAPTIC LOSS IN EARLY AD O'BRIEN, RICHARD J
5P50AG005146-30 2013 $172570 6886 ADMINISTRATIVE CORE Albert, Marilyn
5P50AG005146-30 2013 $540365 6887 CLINICAL CORE Albert, Marilyn
5P50AG005146-29 2012 $186000 6886 ADMINISTRATIVE CORE Albert, Marilyn
5P50AG005146-29 2012 $573853 6887 CLINICAL CORE Albert, Marilyn
5P50AG005146-29 2012 $163262 6890 DATA MANAGEMENT AND STATISTICS BANDEEN-ROCHE, KAREN J
5P50AG005146-29 2012 $85310 6888 EDUCATION CORE Albert, Marilyn
5P50AG005146-29 2012 $225677 6892 MODELING AND ANTI-AMYLOID THERAPY FOR AD: POTENTIAL FOR COGNITIVE RECOVERY SAVONENKO, ALENA
5P50AG005146-29 2012 $223734 6893 NEURONAL ACTIVITY-DEPENDENT SECRETION OF AB AND IMMEDIATE EARLY GENES WORLEY, PAUL F
5P50AG005146-29 2012 $237428 6889 NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-29 2012 $240688 6891 THE ROLES OF AR, TAU AND SYNAPTIC LOSS IN EARLY AD O'BRIEN, RICHARD J
5P50AG005146-28 2011 $1886081 None JOHNS HOPKINS ALZHEIMER'S DISEASE RESEARCH CENTER Albert, Marilyn
2P50AG005146-27 2010 $1900191 None JOHNS HOPKINS ALZHEIMER'S DISEASE RESEARCH CENTER Albert, Marilyn
5P50AG005146-26 2009 $262236 29 EXECUTIVE DEFICITS AND FUNCTIONAL DECLINE IN MCI BRANDT, JASON
5P50AG005146-26 2009 $273490 30 NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD TRONCOSO, JUAN
5P50AG005146-26 2009 $232696 9003 NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-26 2009 $270303 31 SYNAPTIC ABNORMALITIES IN PERFORANT PATH & BACE1 WONG, PHILIP C
5P50AG005146-26 2009 $703835 9001 CLINICAL CORE LYKETSOS, CONSTANTINE G
5P50AG005146-26 2009 $210092 9005 DATA CORE BANDEEN-ROCHE, KAREN J
5P50AG005146-26 2009 $115003 9004 EDUCATION CORE Albert, Marilyn
5P50AG005146-25 2008 $667297 9001 CLINICAL CORE LYKETSOS, CONSTANTINE G
5P50AG005146-25 2008 $198995 9005 DATA CORE BANDEEN-ROCHE, KAREN J
5P50AG005146-25 2008 $109592 9004 EDUCATION CORE Albert, Marilyn
5P50AG005146-25 2008 $253882 29 EXECUTIVE DEFICITS AND FUNCTIONAL DECLINE IN MCI BRANDT, JASON
5P50AG005146-25 2008 $259037 30 NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD TRONCOSO, JUAN
5P50AG005146-25 2008 $221063 9003 NEUROPATHOLOGY CORE TRONCOSO, JUAN
5P50AG005146-25 2008 $256944 31 SYNAPTIC ABNORMALITIES IN PERFORANT PATH & BACE1 WONG, PHILIP C